Associated Papers
Guardian ubiquitin E3 ligases target cancer-associated APOBEC3 deaminases for degradation to promote human genome integrity.
Schwartz I et al.
Nature Communications, 2026
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient.
Valentine H et al.
Cancer Research Communications, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.
Bateman NW et al.
Iscience, 2022
APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA.
Chen Z et al.
The Journal of Biological Chemistry, 2021
Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.
McDonnell MM et al.
Plos Pathogens, 2021
Single-nucleotide polymorphism of the DNA cytosine deaminase APOBEC3H haplotype I leads to enzyme destabilization and correlates with lung cancer.
Hix MA et al.
Nar Cancer, 2020
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.
Calender A et al.
Bmc Medical Genomics, 2018
Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification.
Gu J et al.
Journal of Molecular Biology, 2016
APOBEC3H polymorphisms and susceptibility to HIV-1 infection in an Indian population.
Naruse TK et al.
Journal of Human Genetics, 2016
Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.
Feng Y et al.
The Journal of Biological Chemistry, 2015
APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese.
Sakurai D et al.
Immunogenetics, 2015
Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
Kim EY et al.
Plos Pathogens, 2014
Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements.
Egan JB et al.
Plos One, 2014
Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in children.
Singh KK et al.
Journal of Acquired Immune Deficiency Syndromes (1999), 2013
APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.
Chaipan C et al.
Journal of Virology, 2013
Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.
Zhen A et al.
Plos One, 2012
A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection.
Cagliani R et al.
Evolution; International Journal of Organic Evolution, 2011
Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity.
Li MM et al.
Journal of Virology, 2011
Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.
Wang X et al.
Journal of Virology, 2011
The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity.
Ooms M et al.
Journal of Virology, 2010
The range of human APOBEC3H sensitivity to lentiviral Vif proteins.
Li MM et al.
Journal of Virology, 2010
Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.
Tan L et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2009
Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H.
Harari A et al.
Journal of Virology, 2009
Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.
OhAinle M et al.
Cell Host & Microbe, 2008
Predicting nsSNPs that Disrupt Protein-Protein Interactions Using Docking.
Goodacre N et al.
Ieee/acm Transactions on Computational Biology and Bioinformatics, 0